Companies · Other Health Care

NX Prenatal Inc.

LOUISVILLE · Other Health Care

Diligence memoA one-page analyst read on NX Prenatal Inc. — recommendation, valuation, rhythm, risks.
$8.6M
Total raised · real
3
Rounds
1.0×
Latest step-up
Top 28%
Sector rank · raised
Series A
Latest stage · inferred · Tue Mar 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

NX Prenatal Inc. looks under-valued against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.66× the median modeled value of Series A Other Health Care companies in 2022–2024 (196 peers) — value vs value, same stage and era.
At-risk
  • Last raise 3.3 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

NX Prenatal Inc. is one of 5376 Other Health Care companies tracked from LOUISVILLE. By capital raised it ranks in the upper tier (ahead of 73% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
20
Investors (latest)
2023-08-02
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MPre-Seed · 2017-09-20 Raised $428K (real) Modeled valuation $13M (est)$428K$13MPre-Seed2017Seed · 2020-04-27 Raised $2.1M (real) Modeled valuation $53M (est)$2.1M$53MSeed2020Series A · 2020-04-27 Raised $5.0M (real) Modeled valuation $101M (est)$5.0M$101MSeries A2020Series A · 2023-03-07 Raised $3.1M (real) Modeled valuation $24M (est)$3.1M$24MSeries A2023Series A · 2023-08-02 Raised $3.1M (real) Modeled valuation $21M (est)$3.1M$21MSeries A2023+$2.1M+$5.0M+$3.1M+$3.1MCumulative $14M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$428K · 2017
Seed$2.1M · 2020
Series A$5.0M · 2020
Series A extension$3.1M · 2023
Series A extension$3.1M · 2023

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$24.1M
Base estimate est.
$4.0M
Conservative case
$70.7M
Upside case
$14.2M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $13.2M · 2017-09-202017Seed · modeled $52.9M · 2020-04-27Series A · modeled $100.9M · 2020-04-27Series A · modeled $24.1M · 2023-03-07Series A · modeled $20.9M · 2023-08-022023
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
3.3 yr
Elapsed time used
3.3 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
18 mo
Avg between rounds
$1.5M/yr
Capital velocity
8.8 yr
On record since
2017
First round
5
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 3.5× above median
This company$8.6M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.6× of median
This company$3.1M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 1.1× above median
This company$24.1M
Sector median$22.1M

Raised more than 73% of sector peers (real $). Modeled value above 52% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #137 of 196.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)CareHarmony, Inc. · Series A Raised $17.4M · modeled $145.1M (est)Dragonfly Endoscopy Inc. · Series A Raised $12.7M · modeled $141.8M (est)NuvoAir Holdings, Inc. · Series A Raised $10.7M · modeled $124.9M (est)Post Acute Recovery, Inc. · Series A Raised $14.5M · modeled $122.9M (est)Micro Interventional Devices, Inc. · Series A Raised $14.0M · modeled $118.9M (est)Etiometry Inc. · Series A Raised $15.6M · modeled $114.6M (est)SafKan, Inc. · Series A Raised $13.0M · modeled $108.4M (est)BehaVR Holdings, Inc. · Series A Raised $12.1M · modeled $102.0M (est)Outliers Inc. · Series A Raised $13.6M · modeled $101.6M (est)RevMedica, Inc. · Series A Raised $14.2M · modeled $101.1M (est)Innovoyce LLC · Series A Raised $9.9M · modeled $97.5M (est)Prixz, Inc. · Series A Raised $9.2M · modeled $97.3M (est)NX Prenatal Inc. (this company) Raised $8.6M · modeled $24.1M (est)NX Prenatal Inc.
CompanyStageRaised · realValue · estvs peer med.
CareHarmony, Inc.Series A$17.4M$145.1M3.96×
Dragonfly Endoscopy Inc.Series A$12.7M$141.8M3.87×
NuvoAir Holdings, Inc.Series A$10.7M$124.9M3.41×
Post Acute Recovery, Inc.Series A$14.5M$122.9M3.35×
Micro Interventional Devices, Inc.Series A$14.0M$118.9M3.25×
Etiometry Inc.Series A$15.6M$114.6M3.13×
SafKan, Inc.Series A$13.0M$108.4M2.96×
BehaVR Holdings, Inc.Series A$12.1M$102.0M2.78×
Outliers Inc.Series A$13.6M$101.6M2.77×
RevMedica, Inc.Series A$14.2M$101.1M2.76×
Innovoyce LLCSeries A$9.9M$97.5M2.66×
Prixz, Inc.Series A$9.2M$97.3M2.66×
NX Prenatal Inc. this companySeries A$8.6M$24.1M0.66×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$428K2017-09-20$2.4M$13.2M90%
Seed$2.1M2020-04-27$10.7M$52.9M90%
Series A$5.0M2020-04-27$22.7M$100.9M90%
Series A$3.1M2023-03-07$14.2M$24.1M90%
Series A$3.1M2023-08-02$14.2M$20.9M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$428K2017-09-20
    • First recorded raise — entered as Pre-Seed.
    • 28 investors on this round.
  2. Seed$2.1M2020-04-27
    • Raised again after 31 mo — slower than the ~14 mo sector norm.
    • Round 5.0× larger than the prior — scaling up.
    • 19 investors on this round.
  3. Series A$5.0M2020-04-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.3× larger than the prior — scaling up.
    • 47 investors on this round.
  4. Series A$3.1M2023-03-07
    • Raised again after 34 mo — slower than the ~14 mo sector norm.
    • Round 1.6× smaller than the prior — bridge or down round.
    • 20 investors on this round.
  5. Series A$3.1M2023-08-02
    • Came back fast: 5 mo vs the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 20 investors on this round.
Intelligence
2025 ~Q1
Modeled next raise · ~18mo cadence
$3.1M
Modeled next size est.range $3.1M$5.0M
1.0×
Last step-up
$1.5M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Robert Saunders17 other2017-09
David Adair6 other2020-04
Brian Brohman3 other2017-09
Gail Page3 other2017-09
Mary Lake Polan3 other2020-04
Kevin Bramer1 other2017-09
ALAN MACK2017-09
Registry & provenance

NX Prenatal Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1721472
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
iPill Inc.Other Health CareSeries A$4.5M$15.9Mnetwork1 shared operator · same sector · same stage
EpiEP, Inc.Other Health CareSeries A$20.5M$3.2Mnetwork1 shared operator · same sector · same stage
Verthermia Acquisition, Inc.Other Health CareSeries A$8.5M$25.1Msame sector · same stage
Msa Management Of Columbus, LlcOther Health CareSeries A$8.8M$26.2Msame sector · same stage
Porter Hills FoundationOther Health CareSeries A$8.9M$20.9Msame sector · same stage
Lutheran Life CommunitiesOther Health CareSeries A$9.0M$21.1Msame sector · same stage
CombiMatrix CorpOther Health CareSeries A$9.0M$24.2Msame sector · same stage
HIPnation Operations & Solutions, LLCOther Health CareSeries A$8.1M$27.8Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
NexGelRx, Inc.Other Health CareSeed$3.0M88%
Predigen, Inc.Other Health CarePre-Seed$15.4M86%
BioMedx Group, Inc.Other Health CarePre-Seed$14.0M86%
Medico CX, Inc.Other Health CarePre-Seed$10.1M85%
Genomedx Inc.Other Health CareSeries B$176.3M85%
NeuMoDx Molecular, Inc.Other Health CareSeries B$444.0M85%
Conceivex IncOther Health CareSeed$3.3M85%
Cx Precision Medicine, Inc.Other Health CareSeed$17.9M84%
Frequently asked
How much funding has NX Prenatal Inc. raised?
NX Prenatal Inc. has raised approximately $8.6M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is NX Prenatal Inc.'s estimated valuation?
Provath's modeled valuation for NX Prenatal Inc. is approximately $24.1M (modeled range $4.0M–$70.7M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is NX Prenatal Inc. at?
NX Prenatal Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Tue Mar 07.
What does NX Prenatal Inc. do and where is it based?
NX Prenatal Inc. operates in the Other Health Care sector, based in LOUISVILLE.
Explore related

See where NX Prenatal Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at NX Prenatal Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.